자궁경부암 조직에서 이차원 전기영동과 질량분석을이용한 단백질발현의 변화 분석
Proteomic analyses of cervical cancer tissues by two-dimensional gel electrophoresis and mass spectrometry
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
목적: 자궁경부 암조직에서 이차원 전기영동과 질량분석을 통한 단백질발현의 변화 분석. 연구방법: 정상 자궁경부 조직과 자궁 편평상피세포 암조직을 2-DE완충액을 사용하여 용해시킨 후, IEF를 실시하였다 (pH3-10 linear, IPG strip 17 cm). 그리고 sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)를 실시하고 은 염색을 하였다. 스캔된 젤들은 PDQuest 2-D softwareTM을 사용하여 분석하였고, 변화가 확인된 단백질은 질량분석기를 이용하여 peptide의 스펙트럼을 얻은 후 Swiss-prot/TrEMBL와 Mascot의 데이터 정보 검색을 이용하여 단백질을 동정하였다. 결과: 본 연구에서 정상 자궁경부 조직과 자궁 편평상피세포 암조직에서 9개의 증가된 단백질과 (alpha enolase, Keratin 19 type I, Keratin 20 type I, Keratin 13 type I, beta-actin, Aflatoxin B1 aldehyde reductase 1, Annexin A2, Squamous cell carcinoma antigen 2), 7개의 감소된 단백질 (Annexin 1, Myosin regulatory light chain 2, 14-3-3 protein epsilon, Heat shock 27 kDa protein, Hypothetical protein (DKFZP434C1715), Tumor necrosis factor receptor superfamily member 13B, Smoth muscle protein 22-alpha) 그리고 6의 증가 또는 감소된 단백질 (Tropomyosin 1, Tropomyosin 2, Tropomyosin 3, Serine (or cysteine) proteinase inhibitor, Phosphatidylinositol transfer protein alpha isoform, Src homology 3 domain-containing protein HIP-55)을 확인할 수 있었다. 결론: 자궁경부의 정상조직과 암조직 사이의 이차원 전기영동을 이용한 단백질 발현의 비교를 통하여 서로 다르게 발현되는 단백질 21개를 동정하였고, 이들 단백질 중 9개의 단백질은 기존에 다른 암 조직에서 암 표적물로 발표된 바 있으며, 나머지 12개의 단백질들은 자궁경부 편평 상피세포 암조직에 특이적인 종양표지물로 생각된다.
Abstract
Objective: Comparison of protein expressions by two-dimensional gel electrophoresis (2-DE) in normal cervix and squamous cell carcinoma tissues in Korean women. Methods: Normal cervix and squamous cell carcinoma tissues were solubilized with 2-DE buffer and the first dimension of PROTEAN IEF CELL, isoelectric focusing (IEF), was performed using pH3-10 linear IPG strips of 17 cm. And then running 12% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and sliver stain. Scanned image was analyzed using PDQuest 2-D softwareTM. Protein spot spectrum was identified by assisted laser desorption/ionization-time of fighting (MALDI-TOF) and the protein mass spectrum identifications were performed by searching protein databases of Swiss-prot/TrEMBL, Mascot and MS-FIT. Results: We found 9 up-regulation proteins (Alpha enolase, Keratin 19 type I, Keratin 20 type I, Keratin 13 type I, beta -actin, Aflatoxin B1 aldehyde reductase 1, Annexin A2, Squamous cell carcinoma antigen 2, unknown), 7 down-reguation proteins (Annexin 1, Myosin regulatory light chain 2, 14-3-3 protein epsilon, Heat shock 27 kDa protein, Hypothetical protein (DKFZP434C1715), Tumor necrosis factor receptor superfamily member 13B, Smoth muscle protein 22-alpha) and 6 up and down-regulation proteins (Tropomyosin 1, Tropomyosin 2, Tropomyosin 3, Serine (or cysteine) proteinase inhibitor, Phosphatidylinositol transfer protein alpha isoform, Src homology 3 domain-containing protein HIP-55) between normal cervix and squamous cell carcinoma cell tissues.Conclusion: 2-DE offers total protein expressions between normal cervix and squamous cell carcinoma cell tissues, and searching of differently expressed protein for the diagnostic markers of squamous cell carcinoma tissue.
참고문헌 (39)
- 통계청, "Annual Report on the cause of death statistics 사망원인 통계연보 2001" (2001), 통계청
- Tommasino M, "The Role of TP53 in cervical carcinogenesis", 21(3), pp.307~12 (2003)
- Brenna SM, "Regulation of cell cycles is of key importance in human papillomavirus associated cervical carcinogenesis", 121(3), pp.128~32 (2003)
- Chen Y, "Identification of cervical cancer markers by cDNA and tissue microarrays", 63(8), pp.1927~35 (2003)
- Luo A, "Discovery of Ca -relevant and differentiation-associated genes downregulated in esophageal squamous cell carcinoma using cDNA microarray", pp.1~9 (2003)
- Cheng Q, "Identification of molecular markers for the early detection of human squamous cell carcinoma of the uterine cervix", 86(2), pp.274~81 (2002)
- Van Trappen PO, "A model for co-expression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancer", 87(5), pp.537~44 (2002)
- Alazawi W, "Changes in cervical keratinocyte gene expression associated with integration of human papillomavirus 16", 62(23), pp.6959~65 (2002)
- Cheng Q, "Identification and characterization of genes involved in the carcinogenesis of human squamous cell cervical carcinoma", 98(3), pp.419~26 (2002)
- Wilkins MR, "From proteins to proteomes:large-scale protein identification by two- dimensional electrophoresis and amino acid analysis", 14, pp.61~5 (1996)
- Mortz E, "Improved silver staining protocols for high sensitivity protein identification using matrix-assisted laser desorption", ionization-time of flight analysis, 2001, pp.1(11), 1359~63
- Humphery-Smith I, "Proteome research:complementarity and limitations with respect to the RNA and DNA worlds", 18, pp.1217~42 (1997)
- Pennington SR, "Proteome analysis:from protein characterization to biologycal function", 7, pp.168~73 (1997)
- Oh J, "Annexin-I inhibits PMA-induced c-fos SRE activation by suppressing cytosolic phospholipase A2 signal", 477(3), pp.244~8 (2000)
- Kim YS, "PKCdelta-dependent cleavage and nuclear translocation of annexin A1 by phorbol 12-myristate 13-acetate", 270(20), pp.4089~94 (2003)
- Alldridge LC, "The annexin protein lipocortin 1 regulates the MAPK", ERK pathway, 1999, pp.274(53), 37620~8
- Hannon R, "Aberrant inflammation and resistance to glucocorticoids in annexin 1-", - mouse, 2003, pp.17(2), 253~5
- Vercoutter-Edouart AS, "Proteomic analysis reveals that 14-3-3 sigma is down-regulated in human breast cancer cells", 61(1), pp.76~80 (2001)
- McConnell JE, "a kinase regulator whose expression pattern is modulated in mesenchyme and neuronal differentiation", 169(1), pp.218~28 (1995)
- Cell Signal 2000, "regulation of subcellular localization by molecular interference", 12, pp.703~70 (2000)
- Rosenquist M, "14-3-3 proteins in apoptosis", 36(4), pp.403~8 (2003)
- Solito E, "Dexamethasone induces rapid serine-phosphorylation and membrane translocation of annexin 1 in a human folliculostellate cell line via a novel nongenomic mechanism involving the glucocorticoid receptor", 144(4), pp.1164~74 (2003)
- Yaffe MB, "The structural basis for 14-3-3", 91(7), pp.961~71 (1997)
- Luk SC, "Developmental regulation of 14-3-3 epsilon isoform in rat heart", 68(2), pp.195~9 (1998)
- Kominea A, "Expression of the 27-kDa heat shock protein", 128(8), pp.426~32 (2002)
- Rane MJ, "Heat shock protein 27 controls apoptosis by regulating Akt activation", 278(30), pp.27828~35 (2003)
- Gunst SJ, "focal adhesion and small heat shock proteins in the regulation of actin remodeling and contractility in smooth muscle", 91(2), pp.963~72 (2001)
- Sasaki A, "Prognostic significance of heat shock protein 27 in patients with oral squamous cell carcinoma", 9(2), pp.341~4 (2002)
- Piotrowicz RS, "Heat shock protein 27 kDa expression and phosphorylation regulates endothelial cell migration", 12(14), pp.1481~90 (1998)
- Kaneko K, "Myosin light chain kinase inhibitors can block invasion and adhesion of human pancreatic cancer cell lines", 24(1), pp.34~41 (2002)
- Somlyo AP,, "Ca2+ sensitivity of smooth muscle and nonmuscle myosin II modulated by G proteins", 83(4), pp.1325~58 (2003)
- Von Bulow GU, "NF-AT activation induced by a CAML- interacting member of the tumor necrosis factor receptor superfamily", 278(5335), pp.138~41 (1997)
- Li L, "Evidence for serum response factor-mediated regulatory networks governing SM22alpha transcription in smooth", pp.311~21 (1997)
- Chang YS, "Enolase-alpha is frequently down-regulated in non-small cell lung cancer and predicts aggressive biological behavior", 9(101), pp.3641~4 (2003), Clin Cancer Res
- Arcuri D, "ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor relationship with Myc romoter-binding protein 1", 473(1), pp.47~52 (2000)
- Banks-Schlegel SP, "Growth and differentiation of human esophageal carcinoma cell lines", 46(1), pp.250~8 (1986)
- Raval GN, "Loss of expression of tropomyosin-1 a novel class II tumor suppressor that induces anoikis", 22(40), pp.6194~203 (2003)
- , ~
- Schick C, "Squamous cell carcinoma antigen 2 is a novel serpin that inhibits the chymotrypsin-like proteinases cathepsin G and mast cell chymase", 272(3), pp.1849~55 (1997)
